Mental Disorders: News and Research on Cataplexy

MeSH tree: F03.870.400.800.200.750.500

FDA approves lumryz for narcolepsy

The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release formulation of sodium oxybate to be taken once ...